anonymous
Guest
anonymous
Guest
Dupi Class 2 or Class 3 recall.
I'm not familiar with this info - can someone share?
Dupi Class 2 or Class 3 recall.
Well, duh. Somehow AMGN has made more money on Repatha than the Alliance has on Praluent, and now their volume is catching up too. Everyone's NRx and TRx are getting crushed. AMGN just flipped Tricare and pushed UHC Medicare to parity. That sure looks like an iceberg on the horizon...
Reading these posts for the first time in awhile. I am so glad I got out over a year ago. Regeneron is truly a mess from an organization perspective. I still believe Praluent to be a great product for patients despite the patent infringements, etc.and feel for those of us who put so much work and effort behind the launch with essentially little or no support from leadership. Leadership (or lack thereof) is what has sunk this ship.